Centene Corp., founded in 1984 and headquartered in St. Louis, Missouri, is a leading healthcare enterprise dedicated to providing managed care services to individuals and families. The company primarily focuses on offering Medicaid and Medicare services, as well as health insurance to underinsured populations, leveraging a diverse range of healthcare solutions and technologies to improve access and outcomes.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| CNC 2.45% 2028-07-15 USDCentene Corp. | United States | 2028-07-15 | 2.450 | 5.03 |
| CNC 2.50% 2031-03-01 USDCentene Corp. | United States | 2031-03-01 | 2.500 | 5.56 |
| CNC 2.63% 2031-08-01 USDCentene Corp. | United States | 2031-08-01 | 2.625 | 5.47 |
| CNC 3.00% 2030-10-15 USDCentene Corp. | United States | 2030-10-15 | 3.000 | 5.32 |
| CNC 3.38% 2030-02-15 USDCentene Corp. | United States | 2030-02-15 | 3.375 | 5.42 |
| CNC 3.38% 2030-02-15 USDCentene Corp. | United States | 2030-02-15 | 3.375 | 5.46 |
| CNC 3.38% 2030-02-15 USDCentene Corp. | United States | 2030-02-15 | 3.375 | 5.46 |
| CNC 4.25% 2027-12-15 USDCentene Corp. | United States | 2027-12-15 | 4.250 | 4.63 |
| CNC 4.25% 2027-12-15 USDCentene Corp. | United States | 2027-12-15 | 4.250 | 4.63 |
| CNC 4.25% 2027-12-15 USDCentene Corp. | United States | 2027-12-15 | 4.250 | 4.63 |
| CNC 4.63% - USDCentene Corp. | United States | — | 4.625 | 5.49 |
| CNC 4.63% - USDCentene Corp. | United States | — | 4.625 | 5.49 |
| CNC 4.63% 2029-12-15 USDCentene Corp. | United States | 2029-12-15 | 4.625 | 5.35 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Centene has been an active issuer of bonds since the early 2000s, with significant issuances to support its strategic acquisitions and investments in growth. Notably, the company issued $1 billion in senior notes in 2020 to finance its acquisition of WellCare Health Plans, a transformative deal that expanded its market presence. As of October 2023, Centene's bonds yield around 4.5%, which remains competitive within the healthcare sector, reflecting the company's strong credit profile and ongoing commitment to sustainable growth.